Exclusive Summary

• Backed by prestigious US-FDA and UK-MHRA GMP certifications with an existing US registration, enabling fast-track approvals and conveying high trust in both regulated and emerging markets.
• Manufactured by a top-tier pharmaceutical enterprise, guaranteeing large-scale, reliable supply and exceptional cost competitiveness for bidding processes.
• Acts as a first-line standard-of-care antiviral with superior bioavailability over acyclovir, targeting a massive, recurring demand driven by billions of HSV and VZV patients globally.
• Readily available in both 500mg and 1g strengths, perfectly aligning with clinical guidelines for high-dose treatments like shingles to comprehensively cover all authorized indications.